Rethink the global drug supply chain? Fujifilm CEO forecasts more 'local' future for pharma production

The pharmaceutical industry has long touted the strength of its global supply chain, but a double whammy of COVID-19 and geopolitical standoffs have cast that network into doubt. With the U.S. already launching a full-scale "onshore" effort for drug production, could the future look a little more local?